Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Neuropsychological Tests for the Assessment of Cognitive Impairment in Breast Cancer Survivors

NCT07582770 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07582770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07582770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Neuropsychological Tests for the Assessment of Cognitive Impairment in Breast Cancer Survivors
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
April 30, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer survivors, cancer related cognitive impairment